{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:32:41Z","timestamp":1789680761057,"version":"4.0.1"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.canlet.2019.05.024","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T13:59:20Z","timestamp":1558533560000},"page":"56-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"special_numbering":"C","title":["COMPASS Ascending: Emerging clues regarding the roles of MLL3\/KMT2C and MLL2\/KMT2D proteins in cancer"],"prefix":"10.1016","volume":"458","author":[{"given":"Richard J.","family":"Fagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9126-3030","authenticated-orcid":false,"given":"Andrew K.","family":"Dingwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.05.024_bib1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.bbagrm.2014.03.001","article-title":"Interpreting the language of histone and DNA modifications","volume":"1839","author":"Rothbart","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2019.05.024_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrg3173","article-title":"Histone methylation: a dynamic mark in health, disease and inheritance","volume":"13","author":"Greer","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.molcel.2013.01.038","article-title":"Modification of enhancer chromatin: what, how, and why?","volume":"49","author":"Calo","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2019.05.024_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-biochem-051710-134100","article-title":"The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis","volume":"81","author":"Shilatifard","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.canlet.2019.05.024_bib5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nrc3929","article-title":"Hijacked in cancer: the KMT2 (MLL) family of methyltransferases","volume":"15","author":"Rao","year":"2015","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2019.05.024_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.739","article-title":"When epigenetics kills: MLL fusion proteins in leukemia","volume":"23","author":"Slany","year":"2005","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.canlet.2019.05.024_bib7","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1038\/onc.2016.30","article-title":"The molecular mechanics of mixed lineage leukemia","volume":"35","author":"Slany","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.05.024_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cancergen.2015.01.005","article-title":"The cancer COMPASS: navigating the functions of MLL complexes in cancer","volume":"208","author":"Ford","year":"2015","journal-title":"Cancer Genet"},{"key":"10.1016\/j.canlet.2019.05.024_bib9","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1128\/MCB.06092-11","article-title":"The COMPASS family of H3K4 methylases in Drosophila","volume":"31","author":"Mohan","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2019.05.024_bib10","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1128\/MCB.01181-13","article-title":"The MLL3\/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers","volume":"33","author":"Hu","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2019.05.024_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad9780","article-title":"Epigenetic balance of gene expression by Polycomb and COMPASS families","volume":"352","author":"Piunti","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.canlet.2019.05.024_bib12","doi-asserted-by":"crossref","first-page":"11871","DOI":"10.1073\/pnas.1606857113","article-title":"Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2019.05.024_bib13","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41591-018-0034-6","article-title":"Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2019.05.024_bib14","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1093\/nar\/gkx234","article-title":"MLL3\/MLL4 are required for CBP\/p300 binding on enhancers and super-enhancer formation in brown adipogenesis","volume":"45","author":"Lai","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2019.05.024_bib15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.molcel.2017.06.028","article-title":"A UTX-MLL4-p300 transcriptional regulatory network coordinately shapes active enhancer landscapes for eliciting transcription","volume":"67","author":"Wang","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2019.05.024_bib16","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1128\/MCB.06392-11","article-title":"Histone demethylase UTX and chromatin remodeler BRM bind directly to CBP and modulate acetylation of histone H3 lysine 27","volume":"32","author":"Tie","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2019.05.024_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/21541264.2017.1373890","article-title":"The mixed lineage leukemia 4 (MLL4) methyltransferase complex is involved in transforming growth factor beta (TGF-beta)-activated gene transcription","volume":"9","author":"Baas","year":"2018","journal-title":"Transcription"},{"key":"10.1016\/j.canlet.2019.05.024_bib18","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nm.3943","article-title":"The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development","volume":"21","author":"Ortega-Molina","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2019.05.024_bib19","article-title":"Identification of local clusters of mutation hotspots in cancer-related genes and their biological relevance","author":"Rhee","year":"2018","journal-title":"IEEE ACM Trans. Comput. Biol. Bioinform"},{"key":"10.1016\/j.canlet.2019.05.024_bib20","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s00018-006-6274-5","article-title":"SET domain protein lysine methyltransferases: structure, specificity and catalysis","volume":"63","author":"Qian","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2019.05.024_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.molcel.2017.04.018","article-title":"Mll3 and Mll4 facilitate enhancer RNA synthesis and transcription from promoters independently of H3K4 monomethylation","volume":"66","author":"Dorighi","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2019.05.024_bib22","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/ng.3965","article-title":"Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability","volume":"49","author":"Rickels","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/1878-0261.12041","article-title":"Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5\/RBBP5\/ASH2L complex","volume":"11","author":"Weirich","year":"2017","journal-title":"Mol Oncol"},{"key":"10.1016\/j.canlet.2019.05.024_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13148-015-0075-3","article-title":"Somatic cancer mutations in the MLL3-SET domain alter the catalytic properties of the enzyme","volume":"7","author":"Weirich","year":"2015","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.canlet.2019.05.024_bib25","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.91.22.10610","article-title":"11q23 translocations split the \"AT-hook\" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene","volume":"91","author":"Zeleznik-Le","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2019.05.024_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/MCB.18.1.122","article-title":"The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX","volume":"18","author":"Slany","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2019.05.024_bib27","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/onc.2008.443","article-title":"Alterations of the CxxC domain preclude oncogenic activation of mixed-lineage leukemia 2","volume":"28","author":"Bach","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.05.024_bib28","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1073\/pnas.1436338100","article-title":"MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein","volume":"100","author":"Xia","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2019.05.024_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature02080","article-title":"Methylation at lysine 4 of histone H3 in ecdysone-dependent development of Drosophila","volume":"426","author":"Sedkov","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.05.024_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.gene.2017.06.056","article-title":"Histone H3 lysine 4 methyltransferase KMT2D","volume":"627","author":"Froimchuk","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2019.05.024_bib31","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41388-017-0099-6","article-title":"A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer","volume":"37","author":"Fantini","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.05.024_bib32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.molcel.2014.02.033","article-title":"Enhancer malfunction in cancer","volume":"53","author":"Herz","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2019.05.024_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MOH.0000000000000346","article-title":"Distinct functions of histone H3, lysine 4 methyltransferases in normal and malignant hematopoiesis","volume":"24","author":"Yang","year":"2017","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.canlet.2019.05.024_bib34","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nrc2253","article-title":"MLL translocations, histone modifications and leukaemia stem-cell development","volume":"7","author":"Krivtsov","year":"2007","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2019.05.024_bib35","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026658","article-title":"Mixed-Lineage leukemia fusions and chromatin in leukemia","volume":"7","author":"Krivtsov","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.canlet.2019.05.024_bib36","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2019.05.024_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2019.05.024_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fped.2017.00004","article-title":"MLL-rearranged leukemias-an update on science and clinical approaches","volume":"5","author":"Winters","year":"2017","journal-title":"Front Pediatr"},{"key":"10.1016\/j.canlet.2019.05.024_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1475-2867-10-13","article-title":"Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon","volume":"10","author":"Natarajan","year":"2010","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2019.05.024_bib40","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41588-018-0218-5","article-title":"Promoter bivalency favors an open chromatin architecture in embryonic stem cells","volume":"50","author":"Mas","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ng.3740","article-title":"Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia","volume":"49","author":"Meyer","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1126\/science.1198056","article-title":"The genetic landscape of the childhood cancer medulloblastoma","volume":"331","author":"Parsons","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.canlet.2019.05.024_bib43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature11329","article-title":"Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations","volume":"488","author":"Pugh","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.05.024_bib44","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.05.024_bib45","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2019.05.024_bib47","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2019.05.024_bib48","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ccr.2014.03.016","article-title":"MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia","volume":"25","author":"Chen","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2019.05.024_bib49","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1038\/s41388-018-0273-5","article-title":"KMT2C mediates the estrogen dependence of breast cancer through regulation of ERalpha enhancer function","volume":"37","author":"Gala","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.05.024_bib50","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1016\/j.celrep.2016.08.048","article-title":"Mammary-stem-cell-based somatic mouse models reveal breast cancer drivers causing cell fate dysregulation","volume":"16","author":"Zhang","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2019.05.024_bib51","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.05.024_bib52","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/bjh.12262","article-title":"Gene methylation and silencing of SOCS3 in mantle cell lymphoma","volume":"161","author":"Molavi","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2019.05.024_bib53","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.1158\/0008-5472.CAN-10-2460","article-title":"Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis","volume":"70","author":"Cheung","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.05.024_bib54","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.18632\/oncotarget.1555","article-title":"KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation","volume":"4","author":"Guo","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.05.024_bib55","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jtho.2016.12.011","article-title":"Small cell lung cancer exhibits frequent inactivating mutations in the histone methyltransferase kmt2d\/MLL2: CALGB 151111 (alliance)","volume":"12","author":"Augert","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2019.05.024_bib56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.05.024_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005895","article-title":"Genomic landscape survey identifies SRSF1 as a key oncodriver in small cell lung cancer","volume":"12","author":"Jiang","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib58","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/path.4853","article-title":"Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D","volume":"241","author":"Simbolo","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2019.05.024_bib59","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/jclinpath-2014-202447","article-title":"Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer","volume":"67","author":"Ross","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.canlet.2019.05.024_bib60","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/annonc\/mdw005","article-title":"Clinical correlation of extensive-stage small-cell lung cancer genomics","volume":"27","author":"Dowlati","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2019.05.024_bib61","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/JTO.0000000000000250","article-title":"Therapeutic priority of the PI3K\/AKT\/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis","volume":"9","author":"Umemura","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2019.05.024_bib62","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1158\/2159-8290.CD-16-1337","article-title":"Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies","volume":"7","author":"Jordan","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2019.05.024_bib63","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature07423","article-title":"Somatic mutations affect key pathways in lung adenocarcinoma","volume":"455","author":"Ding","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.05.024_bib64","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.canlet.2019.05.024_bib65","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.3564","article-title":"Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas","volume":"48","author":"Campbell","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib66","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.lungcan.2016.05.021","article-title":"Precision medicine in age-specific non-small-cell-lung-cancer patients: integrating biomolecular results into clinical practice-A new approach to improve personalized translational research","volume":"107","author":"Vavala","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2019.05.024_bib67","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Imielinski","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2019.05.024_bib68","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1038\/srep06036","article-title":"Exome sequencing identifies frequent mutation of MLL2 in non-small cell lung carcinoma from Chinese patients","volume":"4","author":"Yin","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.05.024_bib69","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/annonc\/mdw437","article-title":"Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function","volume":"28","author":"Choi","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2019.05.024_bib70","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbrc.2018.08.143","article-title":"Downregulation of KMT2D suppresses proliferation and induces apoptosis of gastric cancer","volume":"504","author":"Xiong","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2019.05.024_bib71","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00432-018-2625-5","article-title":"High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma","volume":"144","author":"Abudureheman","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.05.024_bib72","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41388-017-0026-x","article-title":"Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4","volume":"37","author":"Lv","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.05.024_bib73","doi-asserted-by":"crossref","first-page":"6556","DOI":"10.1158\/1078-0432.CCR-17-1679","article-title":"KMT2C mutations in diffuse-type gastric adenocarcinoma promote epithelial-to-mesenchymal transition","volume":"24","author":"Cho","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.05.024_bib74","doi-asserted-by":"crossref","first-page":"13234","DOI":"10.1074\/jbc.RA118.003387","article-title":"Mutant p53 regulates enhancer-associated H3K4 monomethylation through interactions with the methyltransferase MLL4","volume":"293","author":"Rahnamoun","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.05.024_bib75","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31723","article-title":"p53 orchestrates DNA replication restart homeostasis by suppressing mutagenic RAD52 and POLtheta pathways","volume":"7","author":"Roy","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.canlet.2019.05.024_bib76","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1210\/me.2011-1198","article-title":"Requirement for MLL3 in p53 regulation of hepatic expression of small heterodimer partner and bile acid homeostasis","volume":"25","author":"Kim","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.canlet.2019.05.024_bib77","doi-asserted-by":"crossref","first-page":"8513","DOI":"10.1073\/pnas.0902873106","article-title":"A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4","volume":"106","author":"Lee","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2019.05.024_bib78","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature15251","article-title":"Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth","volume":"525","author":"Zhu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.05.024_bib79","doi-asserted-by":"crossref","first-page":"17603","DOI":"10.1073\/pnas.1208807109","article-title":"Global identification of MLL2-targeted loci reveals MLL2's role in diverse signaling pathways","volume":"109","author":"Guo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2019.05.024_bib80","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.molimm.2018.11.006","article-title":"Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers","volume":"105","author":"MacFawn","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.canlet.2019.05.024_bib81","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01503","article-title":"H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation","volume":"2","author":"Lee","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.canlet.2019.05.024_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2012.03.025","article-title":"SnapShot: histone lysine methylase complexes","volume":"149","author":"Mohan","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2019.05.024_bib83","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.celrep.2019.02.111","article-title":"PI3K inhibition activates SGK1 via a feedback loop to promote chromatin-based regulation of ER-dependent gene expression","volume":"27","author":"Toska","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2019.05.024_bib84","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.aah6893","article-title":"PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D","volume":"355","author":"Toska","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.canlet.2019.05.024_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa4442","article-title":"PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer","volume":"7","author":"Bosch","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2019.05.024_bib86","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/378505a0","article-title":"Altered Hox expression and segmental identity in Mll-mutant mice","volume":"378","author":"Yu","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.05.024_bib87","first-page":"201","volume":"vol. 30","author":"Ayton","year":"2001"},{"key":"10.1016\/j.canlet.2019.05.024_bib88","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1242\/dev.02302","article-title":"Multiple epigenetic maintenance factors implicated by the loss of Mll2 in mouse development","volume":"133","author":"Glaser","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.canlet.2019.05.024_bib89","doi-asserted-by":"crossref","first-page":"803","DOI":"10.15252\/embr.201439700","article-title":"Paternal H3K4 methylation is required for minor zygotic gene activation and early mouse embryonic development","volume":"16","author":"Aoshima","year":"2015","journal-title":"EMBO Rep."},{"key":"10.1016\/j.canlet.2019.05.024_bib90","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2350-15-49","article-title":"De Novo variants in the KMT2A (MLL) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing","volume":"15","author":"Strom","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib91","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ajhg.2012.06.008","article-title":"De novo mutations in MLL cause Wiedemann-Steiner syndrome","volume":"91","author":"Jones","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib92","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12881-019-0776-0","article-title":"A novel deletion mutation in KMT2A identified in a child with ID\/DD and blood eosinophilia","volume":"20","author":"Zhang","year":"2019","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib93","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.ajhg.2016.10.010","article-title":"Haploinsufficiency of KMT2B, encoding the lysine-specific histone methyltransferase 2B, results in early-onset generalized dystonia","volume":"99","author":"Zech","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib94","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejpn.2017.11.009","article-title":"Review of the phenotype of early-onset generalised progressive dystonia due to mutations in KMT2B","volume":"22","author":"Gorman","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.canlet.2019.05.024_bib95","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ajhg.2012.05.003","article-title":"Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability","volume":"91","author":"Kleefstra","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006864","article-title":"Functional convergence of histone methyltransferases EHMT1 and KMT2C involved in intellectual disability and autism spectrum disorder","volume":"13","author":"Koemans","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib97","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cge.12983","article-title":"Unraveling molecular pathways shared by Kabuki and Kabuki-like syndromes","volume":"94","author":"Lintas","year":"2018","journal-title":"Clin. Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib98","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MPH.0000000000001111","article-title":"Cancer management in Kabuki syndrome: the first case of Wilms tumor and a literature review","volume":"40","author":"Teranishi","year":"2018","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2019.05.024_bib99","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.molcel.2018.04.028","article-title":"MLL4 is required to maintain broad H3K4me3 peaks and super-enhancers at tumor suppressor genes","volume":"70","author":"Dhar","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2019.05.024_bib100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrg1748","article-title":"The epigenetic progenitor origin of human cancer","volume":"7","author":"Feinberg","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib101","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrg.2016.13","article-title":"Epigenetic modulators, modifiers and mediators in cancer aetiology and progression","volume":"17","author":"Feinberg","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2019.05.024_bib102","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846821","article-title":"The lysine-specific methyltransferase KMT2C\/MLL3 regulates DNA repair components in cancer","volume":"20","author":"Rampias","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.canlet.2019.05.024_bib103","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/BJ20121280","article-title":"Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5","volume":"449","author":"Senisterra","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2019.05.024_bib104","doi-asserted-by":"crossref","first-page":"10779","DOI":"10.1038\/s41598-018-28709-y","article-title":"Small molecule inhibition of RAS\/MAPK signaling ameliorates developmental pathologies of Kabuki Syndrome","volume":"8","author":"Tsai","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519303192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519303192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:44:22Z","timestamp":1759592662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519303192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":104,"alternative-id":["S0304383519303192"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.05.024","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COMPASS Ascending: Emerging clues regarding the roles of MLL3\/KMT2C and MLL2\/KMT2D proteins in cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}